[Table/Fig-2]:
Characteristics | Korinthenberg et al., [1] | Dhadke SV et al., [2] | Akbayram S et al., [9] | Our study | |
---|---|---|---|---|---|
1. | Study population (n) | 175 | 40 | 36 | 20 |
Study period | 5 years | 1yr 8mths | 6yrs | 1yr 6mths | |
Age range | 11mth-17.7yrs | 13yrs-40yrs | 6mths-180mths | 16mths-17yrs | |
Male: Female ratio | 1.27:1 | 1.5:1 | 1.25:1 | 2.3:1 | |
2. | Preceding events prior to the illness (%) | 79 | 55 | 69.4 | 50 |
3. | Clinical presentation (%) | ||||
(a) Limb weakness | 69.5 | 100 | 94.4 | 100 | |
(b) Sensory dysfunction | 42 | 32.5 | 27.8 | 25 | |
(c) Cranial nerve dysfunction | 35.6 | 62.5 | 12.0 | 20 | |
(d) Autonomic dysfunction | 19.5 | None | 25.0 | 25 | |
(e) Respiratory insufficiency requiring assisted ventilation | 16 | 32.5 | 8.3 | 35 | |
4. | Albumino-cytological dissociation in CSF analysis (%) | - | 65.3 (26 of 40) | 51.4 | 2 out of 5 |
5. | Electrodiagnostic categorization (%) | ||||
(a) AIDP | 67 | 100 | 69.4 | 22.2 | |
(b) AMAN | 19 | - | 27.8 | 38.9 | |
(c) AMSAN | - | - | 2.8 | 22.2 | |
(d) Unclassified/mixed | 14 | - | - | 16.7 | |
6. | Recipients of IVIG (n) | 70 | 14 | 34 | 16 |
7. | Recipients of plasmapharesis(n) | 19 | 4 | - | 1 |
8. | Outcome (%) | ||||
(a) Complete recovery | 92 (98 of 106) | 75 | 80.5 | 82.4(14 of17) | |
(b) Incomplete recovery | 8 | 5 | 11.2 | 17.6 | |
(c) Death | - | 20 | 8.3 | - |